SEOUL, July 16 (Korea Bizwire) — Im Seung-kwan, newly appointed as the fourth Commissioner of the Korea Disease Control and Prevention Agency (KDCA), pledged Monday to strengthen South Korea’s public health security infrastructure and position the agency as a central command hub for infectious disease crises. Speaking at his inauguration ceremony at KDCA headquarters in Osong, [...]
SEOUL, April 4 (Korea Bizwire) — In a scientific breakthrough that could shape the next generation of vaccines and gene therapies, South Korean researchers have, for the first time, uncovered the precise mechanisms by which messenger RNA (mRNA) vaccines operate inside human cells. The discovery, published this week in the journal Science, comes from a team [...]
SEOUL, Oct. 25 (Korea Bizwire) — South Korean drugmaker SK Bioscience Co. said Tuesday it has signed a deal to join hands with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop messenger RNA (mRNA) vaccines. Under the agreement, SK Bioscience will receive US$140 million for the project from CEPI, an Oslo-based international public-private partnership, [...]
SEOUL, July 30 (Korea Bizwire) — South Korea’s science ministry said Friday the country will spend 7.4 billion won (US$6.4 million) in researching messenger RNA (mRNA) vaccine technology by 2024 in a move to boost its preparedness against infectious diseases. The relatively new type of vaccine has recently been in the spotlight as global pharmaceutical [...]